Residual Risk of Cardiovascular Complications in Case of Adequate Lipid-Lowering Therapy
| Autor: | YaA A Panisheva, VV V Simerzin, IV V Gagloeva, MA A Galkina, OV V Fatenkov |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry 030204 cardiovascular system & hematology Lipid-lowering therapy Residual risk 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Target level Spite General Earth and Planetary Sciences Medicine 030212 general & internal medicine business Intensive care medicine Very high risk General Environmental Science |
| Zdroj: | Science and Innovations in Medicine. 3:19-25 |
| ISSN: | 2618-754X 2500-1388 |
| Popis: | This article is devoted to the problems of residual risk of cardiovascu1ar comp1ications deve1opment for high and very high risk patients under adequate lipid-fowering pharmacotherapy in spite of c^lestera! and tow-density 1ipoproteins target level achievement. Afong with classic risk factors the special atte^ton is given to 1ipoprotein (a) [LP (a)] as the most aggressive factor of cardwvascular system atherosclerotic diseases devetopment and their comp1ications. Great importance is attached to 1ipidopheresis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|